Exscientia to Report First Quarter 2022 Financial Results on May 25, 2022
May 18 2022 - 8:00AM
Business Wire
Company to host conference call and webcast on
May 26, 2022 at 1:30 p.m. BST / 8:30 a.m. ET
Exscientia (Nasdaq: EXAI), an AI-driven pharmatech company
committed to discovering, designing and developing the best
possible drugs in the fastest and most effective manner, will
report financial results for the first quarter ended March 31,
2022, on Wednesday, May 25, 2022 after U.S. market close. Following
the announcement, the Company will host a conference call and
webcast at 1:30 p.m. BST / 8:30 a.m. ET on Thursday, May 26, 2022,
to provide an overview of the company’s precision medicine
platform.
A webcast of the live call can be accessed by visiting the
“Investors and Media” section of the Company’s website at
investors.exscientia.ai. Alternatively, the live conference call
can be accessed by dialing +1 (888) 330 3292 (U.S.), +44 203 433
3846 (U.K.), +1 (646) 960 0857 (International) and entering the
conference ID: 8333895. A replay will be available for 90 days
under "Events and Presentations” in the “Investors and Media”
section of the Exscientia website.
About Exscientia
Exscientia is an AI-driven pharmatech company committed to
discovering, designing and developing the best possible drugs in
the fastest and most effective manner. Exscientia developed the
first-ever functional precision oncology platform to successfully
guide treatment selection and improve patient outcomes in a
prospective interventional clinical study, as well as to progress
AI-designed small molecules into the clinical setting. Our pipeline
demonstrates our ability to rapidly translate scientific concepts
into precision-designed therapeutic candidates, with more than 30
projects underway. By designing better drugs, faster, we believe
the best ideas of science can rapidly become the best medicines for
patients.
Exscientia is headquartered in Oxford (England, U.K.), with
offices in Vienna (Austria), Dundee (Scotland, U.K.), Boston
(Mass., U.S.), Miami (Fla., U.S.), Cambridge (England, U.K.), and
Osaka (Japan).
Visit us at https://www.exscientia.ai or follow us on Twitter
@exscientiaAI.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220518005320/en/
Investors: Sara Sherman investors@exscientia.ai
Media: Amanda Galgay media@exscientia.ai
Exscientia (NASDAQ:EXAI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Exscientia (NASDAQ:EXAI)
Historical Stock Chart
From Jul 2023 to Jul 2024